Treatment Approaches for Adolescent Cannabis Use Disorder
Adolescent cannabis use disorder treatment is critical due to increased psychiatric risks associated with cannabis use in teens. Early intervention can help mitigate the development of psychotic, bipolar, depressive, and anxiety disorders. Clinicians…
Endocannabinoid System Research and Clinical Psychosis Care
Clinical psychosis care benefits from understanding the endocannabinoid system's role in first-episode psychosis. Research highlights predictors of legal involvement during early psychosis. This knowledge aids targeted interventions to improve patient…
Endocannabinoid System Research: Trauma and Substance Use
Pre-trauma insomnia alcohol cannabis risk is a significant predictor of increased substance use following trauma exposure. Research shows that posttraumatic stress disorder partially mediates this relationship. Early identification and treatment of…
Impact of Cannabis Use on Trauma-Focused Treatment Outcomes
Cannabis use and trauma-focused treatment outcomes show comparable effectiveness for individuals with PTSD and substance use disorder. Evidence indicates cannabis does not significantly impair trauma-focused therapy results. This supports continued…
Endocannabinoid System Research: CBD and Glucose Tolerance
This cannabidiol glucose tolerance clinical trial examined the effects of low-dose CBD on glucose metabolism in sedentary adults with overweight or obesity. The study found no significant improvements in glucose tolerance or gut microbiome changes after…
Cannabinoid Clinical Trials: Evidence-Based Pediatric Care
Current evidence supports cannabinoid use in pediatric epilepsy, highlighting cannabidiol's efficacy in seizure disorders. Safety data remains limited outside epilepsy indications. Clinicians should focus on established pediatric cannabinoid use with…
Endocannabinoid System Research: Clinical Evidence Guide
Endocannabinoid system prenatal substance use research reveals complex interactions affecting fetal development. Polysubstance exposure during pregnancy complicates clinical counseling. Understanding these patterns is vital for risk stratification and…
Evaluating Cannabinoid Clinical Trials for Mental Disorders
Cannabinoid clinical trials mental disorders efficacy remains limited with no clear primary treatment established. Current research highlights safety concerns and low certainty evidence. Clinical decisions should prioritize proven therapies while…
Quasi-randomization to Cannabinoid Condition in US Legal Market Cannabis Studies
Quasi-randomization cannabis research addresses challenges in legal market cannabis studies where true randomization is restricted. This method helps identify selection bias between accepters and decliners of cannabinoid condition assignments.…
Recent Cannabinoid Clinical Research April 2026 Digest
This research digest presents recent cannabinoid clinical research April 2026, highlighting 10 peer-reviewed studies. The focus is on clinical evidence and metabolic, neurological, and psychiatric outcomes. These findings provide valuable insights for…
